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Background: The Springburn microelimination project seeks to eliminate hepatitis C (HCV) in an area 
of Glasgow with high rates of socioeconomic deprivation and problem drug use. It utilises point of 
care (POC) testing to increase screening, alongside multidisciplinary assessment/initiation of 
treatment, embedded in a community health centre. Phase 1 focuses on those in community alcohol 
and drug treatment (CAT), phase 2 those previously diagnosed  but lost to follow up (not in CAT 
care) and phase 3 population screening using a home test kit offer. 
 
Description of model of care/intervention: Patients attending Springburn CAT  are offered POC 
testing for HCV (Cepheid Genexpert) and HIV (Oraquick swab) with a view to achieving  WHO targets 
of 90% of patients knowing their HCV status, and  80% of patients with HCV initiated on to 
treatment. Each clinic day is covered by a team member who can assess and initiate treatment: Drug 
Service Doctor, Liver Nurse or Pharmacist. Non invasive assessment of fibrosis (FIB4 or Fibroscan), 
simplified on/post treatment monitoring and pan-genotypic treatments minimise steps in the 
treatment pathway. 
 
Effectiveness: Baseline and interim results are summarised in the table below: 
 
 Baseline Interim (month 4) results 
Total registered with CAT clinic 346 
 
319 
 
New 27 
Deceased 7 
Out of care 33 
Moved care 14 
Number ever tested (%) 300 (86.7) 295 (92.8%) 
Tested within 12 months (%) 98 (28.3%) 181 (60.0%) 
Last test HCV positive (%) 86 (25%) 66 (20.7%) 
New diagnoses  - 7 
On/post treatment (%) 11 (12.8%) 60 (68%) 
 
Conclusion and next steps: A combination of POC testing, simplified treatment algorithms and 
multidisciplinary initiation of treatment leads to high uptake of testing and treatment in a 
community drug treatment setting. Good progress towards elimination goals has been made in a 
short period of time. The project is ongoing and updated results will be presented. 
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